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Introduction Carcinogenesis in the liver involves a series of
pathological and biomedical changes including disorders of
autophagy regulation. Deficiency of autophagy during hepato-
carcinogenesis has been widely reported. However, the regula-
tory mechanism underlying autophagy deficiency has not yet
been fully unveiled. The aim of this study is to understand
the role and function of autophagy-related protein 9b (Atg9b)
in autophagy deficiency and endoplasmic reticulum (ER)
stress-induced cell death.
Material and method To establish the experimental hepatocarci-
nogenesis model, we feed mice with choline deficiency, amino
acid-defined (CDAA) diet for 56 and 72 weeks. Initiation of
liver tumour was assessed by macroscopic and microscopic
analysis. PCR array on autophagy-related gene was conducted
to understand the expression profile of autophagy-related
genes during hepatocarcinogenesis. Murine hepatocyte cell line
AML12 was applied as an in vitro model to assess the ER
stress and cell death under Atg9b deficiency.
Results and discussion Mice fed with CDAA diet initiated liver
tumour at 56 weeks while completely being observed with
liver cancer after 72 weeks. livers of CDAA-fed mice showed
significant autophagy deficiency, ER stress and hepatocyte
death. PCR array analysis showed that a few autophagy-
related gene was differentially regulated during CDAA-induced
hepatocarcinogenesis, among which Atg9b is the most down-
regulated gene. Expression of Atg9b was down-regulated in
HCC tissue compared with non-tumour liver, and was found
gradually reduced during the experimental carcinogenesis.
Reduced expression of Atg9b by RNA interference in AML12
suppressed autophagy induction by ER stress inducers, and
increased ER stress marker expression as well as cell death
when exposed to ER stress inducers. This may be associated
with the failure of degradation of protein aggregates by auto-
phagic flux in Atg9b-deficient AML12 cells. Co-immunopreci-
piatation assay revealed that Atg9b deficiency resulted in
failure in anchoring p62 proteins with autophagy vacuoles.
Conclusion Our findings suggested that Atg9b may play an
important in regulating autophagy deficiency during experi-
mental hepatocarcinogenesis.
PO-017 IS RECQL4 A NOVEL PLAYER IN GLIOBLASTOMA
PATHOGENESIS?
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Introduction Glioblastoma (GBM), the common and aggressive
human primary brain tumour (WHO grade IV), is highly
resistant to standard radio- and chemotherapy. This is partly
due to numerous genetic alterations in oncogenes and DNA
damage repair systems. Despite progress in understanding the
molecular background of GBM and advances in treatment
modalities, survival of GMB patients is only 14 months post-
diagnosis. RECQL4 belongs to RecQ family of ATP-dependent
DNA helicases and plays an important role in genomic integ-
rity and stability maintenance via involvement in DNA replica-
tion, repair, recombination, transcription and telomere
maintenance. Mutations in the human RecQ genes are linked
with cancer predisposition and/or premature ageing. Of all
five human helicases, only RECQL4 is found in mitochondria.
We explored if alterations of RECQL4 expression or functions
contribute to pathogenesis of human GBM.
Material and methods We determined the RECQL4 expression
in various tumour specimens (tumour samples, human primary
and established glioma cell cultures) by qPCR and Western
Blotting. We determined the effect of RECQL4 depletion on
cell viability, proliferation and GBM sphere formation using
MTT metabolism, BrdU incorporation and tumour sphere
forming assays, respectively.
Results and discussions We found the upregulated expression
of RECQL4 in GBM at mRNA and protein levels when com-
pared to non-transformed human astrocytes. This finding was
corroborated by TCGA data analysis. Fractionation of mito-
chondrial and cytosolic fractions from human glioma cells
revealed the presence of RECQL4 in mitochondria. Downre-
gulation (by siRNA) or genetic depletion of RECQL4 (by
CRISPRCas9 knockout) in human glioma LN18 and U87-MG
cells impaired cell viability and proliferation. We found upre-
gulation of RECQL4 expression in GBM sphere cultures,
enriched in glioma stem cells. Transient knock-down of
RECQL4 significantly affected tumour sphere formation as
evidenced by decreased numbers and sizes of cultured spheres.
Conclusion These data indicate that deregulation of RECQL4
expression or function may play an important role in GBM
pathobiology. Our results provide a rationale for further stud-
ies of RECQL4 role in gliomagenesis.
Supported by National Science Centre grants 2015/19/N/
NZ3/02374 (SKK) and 2016/22/M/NZ3/00679 (BK) and the
Foundation for Polish Science TEAM-TECH Core Facility
project ,,NGS platform for comprehensive diagnostics and per-
sonalised therapy in neuro-oncology’ (AK).
PO-018 ACQUIRED DNA DAMAGE IN ADOLESCENT OBESITY –
A PROMOTER AND PREDICTOR OF CANCER?
M Usman*, E Volpi. University of Westminster, Biomedical Sciences, London, UK
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Introduction Epidemiological evidence linking obesity with
increased risk of cancer is steadily growing, although the caus-
ative aspects underpinning this association are only partially
understood. Obesity coincides with deficiencies in micronu-
trients such as Vitamin D, a key player in DNA repair proc-
esses. As a result, vitamin D deficiency in obesity may have a
marked impact on DNA stability and integrity. 8-hydroxygua-
nosine (8-OHdG) is a well-established marker of oxidative
DNA damage that has been identified in higher concentrations
in cancer patients. Here we report, preliminary, unpublished
findings from our study on acquired DNA damage in child-
hood obesity.
Material and methods Body Mass Index (BMI), Waist to Hip
ratio (WHR) and body fat percentage via bioelectrical impe-
dance was assessed in over 70 participants, aged 11–18 and
recruited from National Health Service (NHS) obesity clinics
and schools in London. A non-invasive, integrated evaluation
of urinary 8-OHdG and salivary vitamin D was conducted
using ELISA based methods and compared to markers of
adiposity.
Results and discussions A BMI percentile >99 was found to
be associated with decreased salivary vitamin D and increased
urinary 8-OHdG when compared to healthy weight controls
(BMI=5th-85th percentile). Vitamin D levels in saliva were
found to be inversely correlated with BMI and body fat per-
centage. Urinary 8-OHdG positively correlated with body fat
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percentage and WHR. Most importantly, an inverse correla-
tion between vitamin D in saliva and 8-OHdG in urine was
also identified.
Recent evidence has suggested vitamin D in obesity to be a
consequence of altered behaviour, reduced intestinal absorp-
tion, and sequestration of vitamin D into adipose tissue. As a
result, DNA repair processes against oxidative DNA damage
in obesity may be impaired, resulting in the excess of lesions
including 8-OHdG. The effects of excess 8-OHdG lesions
have been well researched to include various mutations that
can drive carcinogenesis.
Conclusion Our results suggest Vitamin D deficiency in obese
adolescents may play a significant role in triggering oxidative
DNA damage, thus increasing the likelihood of cancer later in life.
PO-019 PHOSPHOPROTEOMICS TO CHARACTERISE DNA
DAMAGE RESPONSE IN MOUSE MAMMARY
TUMOURS OF DIFFERENT PARP INHIBITOR
SUSCEPTIBILITY
1,2F Rolfs*, 2E Gogola, 1S Piersma, 1T Pham, 1J Knol, 2,3S Rottenberg, 2J Jonkers,
1C Jimenez. 1Cancer Center Amsterdam VUmc, OncoProteomics Laboratory, Amsterdam,
The Netherlands; 2The Netherlands Cancer Institute, Division of Molecular Pathology,
Amsterdam, The Netherlands; 3University of Bern, Institute of Animal Pathology – Vetsuisse
Faculty, Bern, Switzerland
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Introduction Triple negative breast cancers show very poor
prognosis, with only limited treatment options. A subgroup of
these tumours is deficient in homologous recombination (HR)
and therefore sensitive to DNA damaging drugs or PARP
inhibitors (PARPi). Unfortunately, resistance to PARPi is often
observed. Therefore, the identification of biomarkers for
PARPi response or status of HR are of importance for person-
alised therapy. The DNA damage response is regulated via
post-translational modifications such as phosphorylation. We
thus study differential phosphorylation events in the context
of different PARPi susceptibility.
Material and methods We used a collection of biopsies from
either untreated or irradiated (15 Gy, 2 hour) HR-deficient
mouse mammary tumours and matched PARPi resistant
tumours which restored HR. Changes in phosphorylation were
examined via titanium dioxide based phosphopeptide enrich-
ment or protein expression profiling using single-shot LC-MS/
MS (label-free).
Results and discussions In total, we identified 14 695 phospho-
peptides and 11 138 high-confidence phosphosites (PS) from
48 individual tumours samples that were measured in dupli-
cates. As proof of concept, we analysed changes in PS in
PARPi naive tumours upon induction of the DNA damage
response via ionising irradiation. We detect known events of
the DNA damage response such as increased phosphorylation
of proteins involved in DNA damage checkpoint or double
strand break repair. Further evaluation of these PS, like
sequence motif analysis, prediction of upstream kinases and
kinase substrate enrichment analysis revealed activation of
ATM/ATR in irradiated tumours as expected. To further proof
the validity of our approach, we analysed samples with known
PARPi resistance mechanism – loss of 53 BP1 expression –
and observed downregulation of PS specific to 53 BP1. We
are now extending our analysis to additional samples sets with
known and unknown PARPi resistance mechanisms.
Conclusion Our data point to the feasibility of using phospho-
proteomics as a tool to study DNA damage response in
BRCA1 deficient tumours with different status of HR and
thus contrasting susceptibility to PARPi.
PO-020 FUNCTIONAL CHARACTERISATION OF VARIANT OF
UNKNOWN SIGNIFICATE IN FAMILIAL BREAST
CANCER
1R Adubeiro, 2AC Antunes, 1C Pinheiro, 2P Santos, 3J Cardoso, 3JB Pereira-Leal,
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and Human Health- Genetics- Oncology and Human Toxicology, Lisboa, Portugal; 2Centro
de Ciências e Tecnologias Nucleares- Instituto Superior Técnico- Universidade de Lisboa,
Centro de Ciências e Tecnologias Nucleares- Instituto Superior Técnico, Bobadela, Portugal;
3Ophiomics – Precision Medicine, Ophiomics – Precision Medicine, Lisboa, Portugal; 4NOVA
Medical School/Faculdade de Ciências Médicas- Universidade Nova de Lisboa, Centre for
Toxicogenomics and Human Health- Genetics- Oncology and Human Toxicology, Lisboa,
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Introduction Familial breast cancer (BC) cases account for
5%–10% of all BC cases, and are essentially correlated with
the prevalence of pathogenic BRCA1 and BRCA2 mutations in
cancer patients. Recent advances in next generation sequencing
(NGS) have enabled panel gene testing, or simultaneous test-
ing for mutations in multiple genes for a clinical condition.
With more widespread genetic testing, an increased detection
of alleles with moderate penetrance without established clinical
guidelines and of variants of unknown significance (VUS) as
either benign or disease-causing will occur. Functional analyses
on VUS may identify pathogenicity, and clearly categorise their
mutational status. We carried-out a proof-of concept in vitro
functional analysis in peripheral blood lymphocytes of VUS-
harbouring individuals and healthy controls assessing the cellu-
lar response to g-radiation.
Material and methods Four samples were collected, one BC
patient with a pathogenic ATM mutation; one BRCA2 VUS
detected without diagnosed disease, and two controls (A, B,
no variant detected). All samples were previously sequenced
by NGS to confirm the presence of pathogenic mutations or
VUS detected in a genetic testing panel. Several methodologies
were selected to evaluate the cellular response to genetic
lesions induced by g-radiation (2Gy): chromosomal aberrations
(CA), micronuclei (MN) and comet assay.
Results and discussions Comet assay results revealed a higher
DNA damage in the patient with a pathogenic ATM mutation
(14% DNA in tail) after irradiation, which might be related
with the non-optimal function of the ATM protein. The
BRCA2 VUS sample also showed a higher%DNA in tail
(6.5%), contrasting with the damage quantified for control
samples (2.8% and 0.9% DNA in tail for control A and B,
respectively). These results revealed that the presence of such
variants might be correlated with their biological function,
being crucial to categorise the mutational status. Regarding
CA and MN, these assays were not sensitive enough to dis-
criminate pathogenic from control samples.
Conclusion Results obtained for comet so far suggest a signifi-
cant difference between variant carriers and controls, which
may indicate an increased susceptibility to ionising radiation.
However, more sensitive assays (e.g. H2AX) will be necessary
allowing more informative results. As this study is a proof-of
concept approach, in the near future the sample size will be
incremented.
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